StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Neogen's enterprise value was $3.91B on Nov 11, 2026, against $2.75B a year earlier. Over the last 5 years it ranged from $1.08B to $6.55B, with a median of $3.57B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.91B+31.7%
2025Dec 31, 2025$2.97B-12.6%
2024Dec 31, 2024$3.40B-32.0%
2023Dec 29, 2023$5.00B+286.2%
2022Dec 30, 2022$1.29B-71.1%
2021Dec 31, 2021$4.48B+16.7%
2020Dec 31, 2020$3.84B+22.6%
2019Dec 31, 2019$3.13B+14.3%
2018Dec 31, 2018$2.74B-8.2%
2017Dec 29, 2017$2.98B-6.5%
2016Dec 30, 2016$3.19B+17.9%
2015Dec 31, 2015$2.71B+15.0%
2014Dec 31, 2014$2.35B+10.4%
2013Dec 31, 2013$2.13B+56.3%
2012Dec 31, 2012$1.36B+50.9%
2011Dec 30, 2011$903.89M-27.1%
2010Dec 31, 2010$1.24B–

More Neogen figures

See a number that looks wrong?